Send the following on WhatsApp
Continue to Chathttps://www.marketscreener.com/quote/stock/ONYX-PHARMACEUTICALS-INC-10344/news/Onyx-Pharmaceuticals-Phase-3-Head-to-Head-ENDEAVOR-Study-Demonstrates-Superiority-of-Kyprolis-c-19953863/?utm_source=whatsapp&utm_medium=social&utm_campaign=share